Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Cengild Medical Berhad is a Malaysia-based investment holding company. The Company operates as a healthcare provider specialized in the diagnosis and treatment of gastrointestinal and liver disease. The Company has around 36,588 sq. ft. medical center, which provides diagnostic and therapeutic facilities with 28 licensed beds, two fully equipped operating theaters, three endoscopy suites, and imaging facilities, such as fibro scan, ultrasonography, computerized tomography (CT) scan, fluoroscopy, angiography equipment for endoscopic retrograde cholangiopancreatography (ERCP)s and other procedures. Its medical center's business activities consist of consultant services and medical management services, which includes nursing services and clinical support services. In addition, it also offers 24-hour outpatient accident and emergency service, health screening, physiotherapy, and histopathology services. Its subsidiaries include Cengild Sdn. Bhd., Galen Primer Sdn. Bhd., and others.
theedgemalaysia.com highlighted four stocks with positive momentum and one stock with negative momentum at Bursa Malaysia's afternoon close on Thursday.
Kedah-based private healthcare provider PMCK Bhd, which is en route to list on the ACE Market of Bursa Malaysia, said an implementation of diagnostic-related fixed healthcare payment would benefit its operations due to its competitive pricing currently.
RHB Retail Research said Cengild Medical Bhd (KL:CENGILD) is eyeing a bullish breakout after testing the immediate resistance level with strong volume.
THE initial public offering pipeline is expected to remain robust this year with Bursa Malaysia Bhd aiming for 42 IPOs, compared with 31 in 2023. However, the new listings may not necessarily fetch higher valuations given that the average price-earnings ratios (PER) have trended downwards over th...
CENGILD MEDICAL BERHAD ("CENGILD MEDICAL" OR THE "COMPANY")
VARIATION OF UTILISATION OF PROCEEDS RAISED FROM THE INITIAL PUBLIC OFFERING ("IPO") ("IPO PROCEEDS")